SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-11-105791
Filing Date
2011-04-22
Accepted
2011-04-22 08:03:46
Documents
8
Effectiveness Date
2011-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 68068
2 GRAPHIC g174254notice1a.jpg GRAPHIC 20358
3 GRAPHIC g174254noticea.jpg GRAPHIC 1778
4 GRAPHIC g174254noticee.jpg GRAPHIC 1739
5 GRAPHIC g174254noticef.jpg GRAPHIC 1800
6 GRAPHIC g174254noticeg.jpg GRAPHIC 8341
7 GRAPHIC g174254noticej.jpg GRAPHIC 1802
8 GRAPHIC g174254noticek.jpg GRAPHIC 1800
  Complete submission text file 0001193125-11-105791.txt   122054
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-15360 | Film No.: 11774695
SIC: 3841 Surgical & Medical Instruments & Apparatus